Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor

BACKGROUND: Sickle cell disease (SCD) patients have unique transfusion considerations during bone marrow transplantation (BMT), including prophylaxis against stroke and alloimmunization. Characterization of transfusion requirements is important for blood bank and clinician patient management.

[1]  J. Gajewski,et al.  A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation. , 2008, Blood.

[2]  H. Lazarus,et al.  High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  H. Lazarus,et al.  Iron overload in hematopoietic cell transplantation , 2008, Bone Marrow Transplantation.

[4]  A. Fischer,et al.  Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. , 2007, Blood.

[5]  J. Klein,et al.  Matched‐related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research , 2007, British journal of haematology.

[6]  S. Donfield,et al.  Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia , 2007, British journal of haematology.

[7]  C. Minniti,et al.  Children’s National Medical Center’s transfusion protocol for sickle hemoglobinopathies , 2006, Immunohematology.

[8]  C. Josephson,et al.  Partners for Life: the transfusion program for patients with sickle cell disease offered at the American Red Cross Blood Services, Southern Region, Atlanta, Georgia , 2006, Immunohematology.

[9]  Melanie Osby,et al.  Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories. , 2005, Archives of pathology & laboratory medicine.

[10]  M. Edwards.  Historical keywords: trial. , 2004, Lancet.

[11]  J. Wingard,et al.  Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease , 2004, Bone Marrow Transplantation.

[12]  D. Srivastava,et al.  Etiology and Outcome of Graft Failure in Pediatric Hematopoietic Stem Cell Transplant Recipients , 2003, Journal of pediatric hematology/oncology.

[13]  O. Castro,et al.  Predicting the effect of transfusing only phenotype‐matched RBCs to patients with sickle cell disease: theoretical and practical implications , 2002, Transfusion.

[14]  R. Adams,et al.  Prospective RBC phenotype matching in a stroke‐prevention trial in sickle cell anemia: a multicenter transfusion trial , 2001, Transfusion.

[15]  C. Pegelow,et al.  Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. , 2000, Blood.

[16]  E. Sariban,et al.  Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium , 1998, Bone Marrow Transplantation.

[17]  S. Davies,et al.  Bone marrow transplantation for sickle cell disease. , 1993, Archives of disease in childhood.

[18]  G. McDonald,et al.  Veno-occlusive Disease of the Liver and Multiorgan Failure after Bone Marrow Transplantation: A Cohort Study of 355 Patients , 1993, Annals of Internal Medicine.

[19]  O. Castro,et al.  Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease , 1990 .

[20]  P. Sperryn,et al.  Blood. , 1989, British journal of sports medicine.

[21]  K. Sullivan,et al.  Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. , 1989, The New England journal of medicine.

[22]  J. Lusher,et al.  The incidence of development of irregular red cell antibodies in patients with sickle cell anemia , 1986, Transfusion.

[23]  A. Look,et al.  Bone-marrow transplantation in a patient with sickle-cell anemia. , 1984, The New England journal of medicine.

[24]  H. Gleichmann,et al.  Over 95% Sensitization against Allogeneic Leukocytes Following Single Massive Blood Transfusion 1 , 1975 .

[25]  Wendell,et al.  Transfusion and Alloimmunization in Sickle Cell Disease , 2003 .

[26]  A. Rimm,et al.  Bone Marrow Transplantation for Severe Aplastic Anemia : Influence of Conditioning and Graft-Versus-Host Disease Prophylaxis Regimens on Outcome , 2003 .

[27]  H. Deeg,et al.  Prevention of graft failure in patients with aplastic anemia. , 1993, Bone marrow transplantation.

[28]  A. Rimm,et al.  Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. , 1992, Blood.

[29]  N. Luban.  Variability in rates of alloimmunization in different groups of children with sickle cell disease: effect of ethnic background. , 1989, The American journal of pediatric hematology/oncology.

[30]  R. Nuscher,et al.  Bone marrow transplantation. , 1977, The American journal of nursing.

[31]  H. Gleichmann,et al.  Over 95 per cent sensitization against allogeneic leukocytes following single massive blood transfusion. , 1975, Vox sanguinis.